Key result
Socioeconomic, racial, and ethnic disparities in patients with pulmonary arterial hypertension create significant barriers to healthcare delivery and may lead to worse clinical outcomes.
Why the study?
Underrepresented patients with pulmonary arterial hypertension may be at risk for worse outcomes, and whether genetic roles in pathogenesis also impact minorities is incompletely understood.
Addressing socioeconomic, racial, and ethnic disparities is a fundamental step toward personalized medicine and improving care for patients with pulmonary arterial hypertension.
Health disparities have a major impact in the quality of life and level of clinical care received in minority populations in the United States. Underrepresented patients with pulmonary arterial hypertension (PAH) may be at risk for worse outcomes. Furthermore, advances in biomedical research have provided extensive knowledge on the genetic role in the pathogenesis of PAH but whether these also impact minorities is incompletely understood. Health disparities in patients with PAH create an enormous barrier in health care delivery. Understanding the contributors to health disparity represent a fundamental step towards personalized medicine and further improvement in PAH care.
No takes yet. Share an insight, caveat, or question.
Talwar et al. (2022) conducted a review in Pulmonary arterial hypertension. Socioeconomic, racial, and ethnic disparities in patients with pulmonary arterial hypertension create significant barriers to healthcare delivery and may lead to worse clinical outcomes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: